Login
Israel-Hamas Conflict
Independence Day
Social Media
Floods
Boxing
Soccer
Latin America
World Cup
Natural Disasters
Amazon
Cryptocurrency
Donald Trump
Formula 1
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

AstraZeneca, Daiichi Sankyo Obtain FDA Nod for Datroway

Summary by drugstorenews.com
Datroway is used to treat an advanced form of non-small cell lung cancer in adults who had received prior treatment.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
drugstorenews.comdrugstorenews.com

AstraZeneca, Daiichi Sankyo obtain FDA nod for Datroway

Datroway is used to treat an advanced form of non-small cell lung cancer in adults who had received prior treatment.

Read Full Article
Managed Healthcare ExecutiveManaged Healthcare Executive

FDA Grants Accelerated Approval to Datroway for Previously Treated EGFR-Mutated Lung Cancer

Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Managed Healthcare Executive broke the news in on Tuesday, July 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

FDA icon

FDA

United States icon

United States

News
For You
SearchBlindspotLocal